That's an excellent question. We are doing our best to distinguish the various funding amounts made available to COVAX. Through that mechanism, we endeavour not only to purchase, distribute and transport doses, but also to provide cold chain and technical support to countries in need.
Dose equivalency is an issue we discuss with the G7 and OECD to ensure a consistent approach. I'm referring to the 87 million doses, the equivalent number of doses procured through COVAX with Canada's financial contribution. With the assistance of the WHO, UNICEF and other partners, we are supporting the delivery and administration of doses, which that calculation does not include.